Vanderbilt-Ingram Cancer Center
MD Anderson Cancer Center
Cathy Eng, MD, FACP, FASCO, Professor of Medicine, Hematology and Oncology, is the David H. Johnson Endowed Chair of Surgical and Medical Oncology, Co-Director of GI Oncology and the Co-Leader of the Gastrointestinal Cancer Research Program, Director of the Young Adults Cancers Program, Chair, Developmental Research Program for the GI SPORE. She was the Ambassador for the American Cancer Society ResearcHERS campaign (2020-2022). She is currently the Director for Strategic Relations. She is a highly sought mentor and served on the Vanderbilt-Ingram Mentorship Council and is currently a mentor on the T-32 grant and serves on the Professional Development Mentor. She continues to assume leadership positions devoted to development of phase I-III clinical trials using novel therapeutics for biomarker discovery and enhanced drug utilization in colorectal, appendiceal and anal cancer patients.
Nationally, Dr. Eng has also been highly active serving on multiple committees for ASCO, ECOG, and SWOG. She was chosen for the ASCO Leadership Development Program, ASCO Social Media Committee, the ASCO Colorectal Guidelines Committee, ASCO Scientific Program Committee (Colorectal Cancer Track) and the ASCO Communications Committee. She was the co-chair of the SWOG Rectal/Anal Cancer Subcommittee; the Vice-Chair for the SWOG GI Committee; the Chairman of the NCI Rectal/Anal Task Force (two terms), NCI GI Steering Committee, and is now the co-Chair of the NCI GI Steering Committee. She was recently chosen for the President Biden'ts Cancer Moonshot White House Colorectal Cancer Forum.
She has published in many peer-reviewed journals and served on many national grant review panels.
Thursday, March 30, 2023
8:30 AM – 8:45 AM ET
Thursday, March 30, 2023
9:15 AM – 9:30 AM ET
Thursday, March 30, 2023
11:15 AM – 11:30 AM ET
Session 6: Perspectives on Clinical Trial Development in Anal Cancer
Thursday, March 30, 2023
3:15 PM – 4:00 PM ET
Friday, March 31, 2023
7:45 AM – 8:00 AM ET
Session 10: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Discussion
Friday, March 31, 2023
12:00 PM – 12:15 PM ET
Friday, March 31, 2023
2:30 PM – 2:45 PM ET
Saturday, April 1, 2023
7:45 AM – 8:00 AM ET
Saturday, April 1, 2023
8:30 AM – 8:45 AM ET
Session 19: Rising Incidence of Early-Onset GI Malignancies: Pancreatic, CRC, and Gastric
Saturday, April 1, 2023
12:45 PM – 1:30 PM ET
Wednesday, August 2, 2023
8:00 AM – 8:15 AM ET
Wednesday, August 2, 2023
8:45 AM – 9:00 AM ET
Wednesday, August 2, 2023
9:45 AM – 10:00 AM ET
Wednesday, August 2, 2023
4:20 PM – 4:30 PM ET
Session 7: Perspectives on Clinical Trial Development in Anal Cancer
Wednesday, August 2, 2023
4:45 PM – 5:20 PM ET
Wednesday, August 2, 2023
5:20 PM – 5:30 PM ET
Thursday, August 3, 2023
8:00 AM – 8:15 AM ET
Thursday, August 3, 2023
9:50 AM – 10:00 AM ET
Thursday, August 3, 2023
12:05 PM – 12:15 PM ET
Thursday, August 3, 2023
1:05 PM – 1:15 PM ET
Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Discussion
Thursday, August 3, 2023
3:15 PM – 3:30 PM ET
Thursday, August 3, 2023
4:20 PM – 4:30 PM ET
Thursday, August 3, 2023
5:20 PM – 5:30 PM ET
Friday, August 4, 2023
9:00 AM – 9:15 AM ET
Friday, August 4, 2023
9:45 AM – 10:00 AM ET
Friday, August 4, 2023
10:45 AM – 11:00 AM ET
Friday, August 4, 2023
11:50 AM – 12:00 PM ET
Session 18: Rising Incidence of Early-Onset GI Malignancies: Pancreatic, CRC, and Gastric
Friday, August 4, 2023
12:30 PM – 1:05 PM ET
Friday, August 4, 2023
1:05 PM – 1:15 PM ET
Friday, August 4, 2023
4:15 PM – 4:20 PM ET
Thursday, September 28, 2023
8:00 AM – 8:15 AM ET
Thursday, September 28, 2023
8:45 AM – 9:00 AM ET
Thursday, September 28, 2023
9:30 AM – 9:45 AM ET
Session 3: Perspectives on Clinical Trial Development in Anal Cancer
Thursday, September 28, 2023
11:00 AM – 11:35 AM ET
Thursday, September 28, 2023
11:35 AM – 11:45 AM ET
Thursday, September 28, 2023
3:55 PM – 4:05 PM ET
Friday, September 29, 2023
8:00 AM – 8:15 AM ET
Friday, September 29, 2023
9:35 AM – 9:45 AM ET
Friday, September 29, 2023
11:35 AM – 11:45 AM ET
Friday, September 29, 2023
12:20 PM – 12:30 PM ET
Friday, September 29, 2023
2:10 PM – 2:20 PM ET
Friday, September 29, 2023
2:50 PM – 3:05 PM ET
Friday, September 29, 2023
3:55 PM – 4:05 PM ET
Session 15: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Discussion
Friday, September 29, 2023
4:35 PM – 4:50 PM ET
Friday, September 29, 2023
5:25 PM – 5:35 PM ET
Saturday, September 30, 2023
8:00 AM – 8:15 AM ET
Saturday, September 30, 2023
8:50 AM – 9:00 AM ET
Saturday, September 30, 2023
9:00 AM – 9:35 AM ET
Saturday, September 30, 2023
9:35 AM – 9:45 AM ET
Saturday, September 30, 2023
11:50 AM – 12:05 PM ET
Saturday, September 30, 2023
1:10 PM – 1:20 PM ET
Session 21: Rising Incidence of Early-Onset GI Malignancies: Pancreatic, CRC, and Gastric
Saturday, September 30, 2023
1:20 PM – 1:55 PM ET
Saturday, September 30, 2023
1:55 PM – 2:05 PM ET